CAR T-cell Therapy Heals Aging Guts
Analysis based on 7 articles · First reported Jan 04, 2026 · Last updated Jan 05, 2026
This medical breakthrough by Cold Spring Harbor Laboratory could significantly impact the biotechnology and healthcare industries by opening new avenues for treating age-related gut health issues and radiation damage. The development of CAR T-cell therapy for this purpose may lead to increased investment and research in related fields, potentially benefiting companies involved in immunotherapy and regenerative medicine.
Researchers at Cold Spring Harbor Laboratory, led by Corina Amor Vegas, Semir Beyaz, and Onur Eskiocak, have discovered a novel application for CAR T-cell therapy to help aging intestines heal themselves. By targeting senescent cells that accumulate over time, the treatment boosted gut regeneration, reduced inflammation, and improved nutrient absorption in mice. The therapy also protected the intestine from radiation damage, with benefits lasting up to a year. Early results in human intestinal and colorectal cells suggest strong therapeutic potential for older adults and cancer patients suffering from conditions like leaky gut syndrome. This breakthrough builds on earlier research into cellular senescence and could pave the way for future clinical trials.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard